| Anti-infective | |||||
|---|---|---|---|---|---|
| Anti-infective / Fungal infection | |||||
| Posaconazole | On Formulary | ||||
| amphotericin B | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
AMPHOTERICIN
Hospital use only |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
AMPHOTERICIN B - FUNGIZONE
Nebulised treatment of azole-resistant pulmonary Aspergillus - on Formulary Hospital Only |
|||||
| caspofungin | Hospital Only | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
CF drug doses |
|||||
| Powder for solution for infusion | |||||
| Caspofungin (Non-proprietary) | Hospital Only | ||||
| Cancidas (Merck Sharp & Dohme (UK) Ltd) | Hospital Only | ||||
| fluconazole | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
FLUCONAZOLE
Injection formulation is Hospital Only |
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
| Oral suspension | |||||
| Fluconazole (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
| Diflucan (Pfizer Ltd) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
| Solution for infusion | |||||
| Fluconazole (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Fluconazole
Injection formulation is Hospital Use Only |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
| flucytosine | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH |
|||||
|
FLUCYTOSINE
Injection Hospital use only |
|||||
| griseofulvin | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
| itraconazole | Hospital Only | ||||
|
Cystic Fibrosis Drug Doses
See attached. |
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
| micafungin | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
MICAFUNGIN
Hospital Use Only |
|||||
| nystatin | Off Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| voriconazole | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
VORICONAZOLE
Injection formulation is Hospital use only |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Oral suspension | |||||
| VFEND (Pfizer Ltd) | On Formulary | ||||
| Anti-infective / Pneumocystis pneumonia | |||||
| atovaquone | Hospital Only | ||||
|
ATOVAQUONE
Hospital use only |
|||||
| Oral suspension | |||||
| Wellvone (GlaxoSmithKline UK Ltd) | Hospital Only | ||||
|
Wellvone®
Hospital use only |
|||||
| co-trimoxazole | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
CO-TRIMOXAZOLE
Injection formulation is Hospital Only |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
| Oral suspension | |||||
| Co-trimoxazole (Non-proprietary) | On Formulary | ||||
| dapsone | Hospital Only | ||||
| pentamidine isetionate | On Formulary | ||||
|
PENTAMIDINE ISETIONATE
Hospital use only |
|||||
| Powder for solution for injection | |||||
| Pentacarinat (Sanofi) | On Formulary | ||||
|
Pentacarinat®
Hospital use only |
|||||
| Anti-infective / Chronic hepatitis B | |||||
| lamivudine | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
LAMIVUDINE
Hospital use only |
|||||
| peginterferon alfa | On Formulary |
NICE TA300 |
|||
|
PEGINTERFERON ALFA
For Hospital Use Only |
|||||
| Solution for injection | |||||
| Pegasys (Aspire Pharma Ltd) | On Formulary | ||||
|
Pegasys®
For Hospital Use Only |
|||||
| tenofovir disoproxil | On Formulary | ||||
|
TENOFOVIR DISOPROXIL
Hospital use only |
|||||
| Anti-infective / Chronic hepatitis C | |||||
| peginterferon alfa | On Formulary |
NICE TA300 |
|||
|
PEGINTERFERON ALFA
For Hospital Use Only |
|||||
| Solution for injection | |||||
| Pegasys (Aspire Pharma Ltd) | On Formulary | ||||
|
Pegasys®
For Hospital Use Only |
|||||
| ribavirin | Hospital Only |
NICE TA300 |
|||
|
RIBAVIRIN
Hospital use only |
|||||
| Anti-infective / HIV infection | |||||
| abacavir | Hospital Only | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
ABACAVIR
Hospital use only |
|||||
|
CAUTION-patients with HLA-B*5701 Allele
Patients with HLA-B*5701 Allele should not receive Abacavir due to higher risk of hypersensititivy reaction. HLA-B*5701 status must be checked before initiating Abacavir, positive status is a contra-indication for Abacavir. |
|||||
| abacavir with dolutegravir and lamivudine | Hospital Only | ||||
|
Caution-patients with HLA-B*5701 Allele
Patients with HLA-B*5701 Allele should not receive Abacavir due to higher risk of hypersensititivy reaction. HLA-B*5701 status must be checked before initiating Abacavir, positive status is a contra-indication for Abacavir. |
|||||
| abacavir with lamivudine | On Formulary | ||||
|
Caution-Patients with HLA-B*5701 Allele
Patients with HLA-B*5701 Allele should not receive Abacavir due to higher risk of hypersensititivy reaction. HLA-B*5701 status must be checked before initiating Abacavir, positive status is a contra-indication for Abacavir. |
|||||
|
Hospital use only
|
|||||
| abacavir with lamivudine and zidovudine | On Formulary | ||||
|
Caution-patients with HLA-B*5701 Allele
Patients with HLA-B*5701 Allele should not receive Abacavir due to higher risk of hypersensititivy reaction. HLA-B*5701 status must be checked before initiating Abacavir, positive status is a contra-indication for Abacavir. |
|||||
|
Hospital Use Only
|
|||||
| atazanavir | On Formulary | ||||
|
ATAZANAVIR
Hospital use only |
|||||
| darunavir | Hospital Only | ||||
|
DARUNAVIR
Hospital use only |
|||||
| Oral suspension | |||||
| Prezista (Janssen-Cilag Ltd) | Hospital Only | ||||
|
Prezista®
Hospital use only |
|||||
| efavirenz | On Formulary | ||||
|
EFAVIRENZ
Hospital use only |
|||||
| emtricitabine | On Formulary | ||||
|
EMTRICITABINE
Hospital use only |
|||||
| Oral solution | |||||
| Emtriva (Gilead Sciences Ltd) | On Formulary | ||||
|
Emtriva®
Hospital use only |
|||||
| enfuvirtide | On Formulary | ||||
|
ENFUVIRTIDE
Hospital Use Only |
|||||
| Powder and solvent for solution for injection | |||||
| Fuzeon (Roche Products Ltd) | On Formulary | ||||
|
Fuzeon®
Hospital Use Only |
|||||
| etravirine | On Formulary | ||||
|
ETRAVIRINE
Hospital use only |
|||||
| fosamprenavir | On Formulary | ||||
|
FOSAMPRENAVIR
Hospital use only |
|||||
| lamivudine | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
LAMIVUDINE
Hospital use only |
|||||
| Oral solution | |||||
| Epivir (ViiV Healthcare UK Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Epivir®
Hospital use only |
|||||
| lamivudine with dolutegravir | Hospital Only | ||||
| lopinavir with ritonavir | On Formulary | ||||
|
LOPINAVIR WITH RITONAVIR
Hospital use only |
|||||
| Oral solution | |||||
| Kaletra (AbbVie Ltd) | On Formulary | ||||
|
Kaletra®
Hospital use only |
|||||
| maraviroc | On Formulary | ||||
|
MARAVIROC
Hospital Use Only |
|||||
| nevirapine | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
NEVIRAPINE
Hospital Use Only |
|||||
| Modified-release tablet | |||||
| Nevirapine (Non-proprietary) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 2016 Barts Health 2016 |
|||||
|
Nevirapine
Hospital Use Only |
|||||
| Oral suspension | |||||
| Viramune (Boehringer Ingelheim Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Viramune®
Hospital Use Only |
|||||
| raltegravir | On Formulary | ||||
|
RALTEGRAVIR
Hospital use only |
|||||
| ritonavir | Hospital Only | ||||
|
RITONAVIR
Hospital use only |
|||||
| tenofovir disoproxil | On Formulary | ||||
|
TENOFOVIR DISOPROXIL
Hospital use only |
|||||
| zidovudine | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
ZIDOVUDINE
Hospital use only |
|||||
| Oral solution | |||||
| Retrovir (ViiV Healthcare UK Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Retrovir®
Hospital use only |
|||||
| Solution for infusion | |||||
| Retrovir (ViiV Healthcare UK Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Retrovir®
Hospital use only |
|||||
| Anti-infective / Respiratory syncytial virus | |||||
| palivizumab | On Formulary | ||||
|
PALIVIZUMAB
Hospital use only |
|||||
| Solution for injection | |||||
| Synagis (AstraZeneca UK Ltd) | On Formulary | ||||
|
Synagis®
Hospital use only |
|||||
| ribavirin | Hospital Only |
NICE TA300 |
|||
|
RIBAVIRIN
Hospital use only |
|||||
| Anti-infective / Herpesvirus infections | |||||
| aciclovir | On Formulary | ||||
|
ACICLOVIR
Intravenous formulation is Hospital Use Only |
|||||
|
Paediatric Haematology & Oncology: Supportive Care Protocols
see attached |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2019
Refer to Microguide |
|||||
| Oral suspension | |||||
| Aciclovir (Non-proprietary) | On Formulary | ||||
|
Paediatric Haematology & Oncology: Supportive Care Protocols
see attached |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2019
Refer to Microguide |
|||||
| Zovirax (GlaxoSmithKline UK Ltd) | On Formulary | ||||
|
Paediatric Haematology & Oncology: Supportive Care Protocols
see attached |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2019
Refer to Microguide |
|||||
| Solution for infusion | |||||
| Aciclovir (Non-proprietary) | On Formulary | ||||
|
ACICLOVIR
Intravenous formulation is Hospital Use Only |
|||||
|
Paediatric Haematology & Oncology: Supportive Care Protocols
see attached |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2019
Refer to Microguide |
|||||
| Powder for solution for infusion | |||||
| Aciclovir (Non-proprietary) | On Formulary | ||||
| Zovirax I.V. (GlaxoSmithKline UK Ltd) | On Formulary | ||||
| valaciclovir | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
VALACICLOVIR
Hospital use only |
|||||
| Anti-infective / Cytomegalovirus infections | |||||
| foscarnet sodium | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
FOSCARNET SODIUM
Intravenous formulation is Hospital Use Only |
|||||
| Solution for infusion | |||||
| Foscavir (Clinigen Healthcare Ltd) | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Foscavir®
Intravenous formulation is Hospital Use Only |
|||||
| ganciclovir | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
GANCICLOVIR
Hospital use only |
|||||
| Anti-infective / Influenza | |||||
| oseltamivir | On Formulary |
NICE TA158 NICE TA168 |
|||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Public Health England Guidance on Influenza treatment and prophylaxis
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
| Oral suspension | |||||
| Tamiflu (Roche Products Ltd) | On Formulary | ||||
|
Public Health England Guidance on Influenza treatment and prophylaxis
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
| zanamivir | On Formulary |
NICE TA158 NICE TA168 |
|||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Public Health England Guidance on Influenza treatment and prophylaxis
|
|||||
|
Contacting Micro 2015
|
|||||
| Anti-infective / Amoebic infection | |||||
| metronidazole | On Formulary | ||||
|
Metronidazole
Please note that the injection is HOSPITAL PHARMACY. |
|||||
| Anti-infective / Helminth infection | |||||
| albendazole | On Formulary | ||||
| Chewable tablet | |||||
| Albendazole (Non-proprietary) | On Formulary | ||||
| diethylcarbamazine | Off Formulary | ||||
| ivermectin | On Formulary | ||||
| levamisole | On Formulary | ||||
|
Difficult to Obtain Letter
Difficult to Obtain Letter (2) |
|||||
|
LEVAMISOLE
Hospital only |
|||||
|
Difficult to Obtain Letter
Difficult to Obtain Letter |
|||||
| mebendazole | On Formulary | ||||
| Chewable tablet | |||||
| Vermox (Janssen-Cilag Ltd) | On Formulary | ||||
| Oral suspension | |||||
| Vermox (Janssen-Cilag Ltd) | On Formulary | ||||
| praziquantel | Off Formulary | ||||
| Anti-infective / Leishmaniasis | |||||
| amphotericin B | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
AMPHOTERICIN
Hospital use only |
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
AMPHOTERICIN B - FUNGIZONE
Nebulised treatment of azole-resistant pulmonary Aspergillus - on Formulary Hospital Only |
|||||
| pentamidine isetionate | On Formulary | ||||
|
PENTAMIDINE ISETIONATE
Hospital use only |
|||||
| Powder for solution for injection | |||||
| Pentacarinat (Sanofi) | On Formulary | ||||
|
Pentacarinat®
Hospital use only |
|||||
| Anti-infective / Malaria | |||||
| artemether with lumefantrine | Hospital Only | ||||
|
PHE Malaria prevention guideline 2019
see link |
|||||
| atovaquone with proguanil hydrochloride | On Formulary | ||||
| chloroquine | On Formulary | ||||
|
PHE prevention of Malaria 2019
PHE prevention of Malaria 2019 |
|||||
| Oral solution | |||||
| Malarivon (Wallace Manufacturing Chemists Ltd) | On Formulary | ||||
| doxycycline | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
ACMP guidelines on malaria prevention in UK travellers
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
| mefloquine | On Formulary | ||||
|
ACMP guidelines on malaria prevention in UK travellers
|
|||||
| primaquine | On Formulary | ||||
|
PRIMAQUINE
Hospital use only |
|||||
|
ACMP guidelines on malaria prevention in UK travellers
ACMP guidelines on malaria prevention in UK travellers |
|||||
| quinine | On Formulary | ||||
|
ACMP guidelines on malaria prevention in UK travellers
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Anti-infective / Toxoplasmosis | |||||
| pyrimethamine | On Formulary | ||||
|
PYRIMETHAMINE
Hospital use only |
|||||
| spiramycin | Off Formulary | ||||
| Anti-infective / Bacterial infection | |||||
| Fidaxomicin | On Formulary | ||||
| amikacin | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Line locks
Formulary |
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Antibiotic line lock Guideline - paeds
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
AMIKACIN
Hospital Only |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
See attached |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Temporary shortage
13.12.19 Amikacin is restricted currently due to a national shortage-please see attached memo |
|||||
| Solution for injection | |||||
| Amikacin (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Antibiotic line lock Guideline - paeds
|
|||||
|
Amikacin
Hospital Only |
|||||
| amoxicillin | On Formulary | ||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
AMOXICILLIN
Amoxicillin injection is hospital only |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
| Oral suspension | |||||
| Amoxicillin (Non-proprietary) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
| Powder for solution for injection | |||||
| Amoxicillin (Non-proprietary) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
Amoxicillin
Amoxicillin injection is hospital only |
|||||
| ampicillin | Off Formulary | ||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
| azithromycin | On Formulary | ||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
| Oral suspension | |||||
| Azithromycin (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
| aztreonam | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
| Powder for solution for injection | |||||
| Azactam (Bristol-Myers Squibb Pharmaceuticals Ltd) | On Formulary | ||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Contacting Micro 2015
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
| Powder and solvent for nebuliser solution | |||||
| Cayston (Gilead Sciences Ltd) | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
| benzylpenicillin sodium | On Formulary | ||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Penicillin allergy poster
|
|||||
|
BENZYLPENICILLIN SODIUM
Hospital use only |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
| Powder for solution for injection | |||||
| Benzylpenicillin sodium (Non-proprietary) | On Formulary | ||||
| cefaclor | Off Formulary | ||||
|
Contacting Micro 2015
|
|||||
| Modified-release tablet | |||||
| Distaclor MR (Flynn Pharma Ltd) | On Formulary | ||||
| Oral suspension | |||||
| Distaclor (Flynn Pharma Ltd) | On Formulary | ||||
| cefalexin | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Paediatric Antibiotics Guideline Barts Health
See attached |
|||||
|
Neonatal Formulary Barts Health
See attached |
|||||
| Oral suspension | |||||
| Cefalexin (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
| cefixime | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| cefotaxime | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
CEFOTAXIME
Hospital Only |
|||||
|
NEONATAL FORMULARY VERSION HEALTH
See attached |
|||||
| Powder for solution for injection | |||||
| Cefotaxime (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
|
|||||
|
Contacting Micro 2015
|
|||||
|
Cefotaxime
Hospital Only |
|||||
| cefradine | Off Formulary | ||||
|
Contacting Micro 2015
|
|||||
| ceftazidime | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
CEFTAZIDIME
Hospital Only |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
NEONATAL FORMULARY 2018 BARTS HEALTH
Neonatal formualry |
|||||
| Powder for solution for injection | |||||
| Ceftazidime (Non-proprietary) | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
|
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
Ceftazidime
Hospital Only |
|||||
| ceftriaxone | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Peri-orbital cellulitis in children protocol 2012
|
|||||
|
Contacting Micro 2015
|
|||||
|
CEFTRIAXONE
Hospital Only |
|||||
| Powder for solution for injection | |||||
| Ceftriaxone (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
Peri-orbital cellulitis in children protocol 2012
|
|||||
|
Contacting Micro 2015
|
|||||
|
Ceftriaxone
Hospital Only |
|||||
| cefuroxime | On Formulary | ||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Contacting Micro 2015
|
|||||
|
CEFUROXIME
Injection formulation is Hospital Only Cefuroxime 5% eye drops (preservative-free) is hospital only |
|||||
| Oral suspension | |||||
| Zinnat (Sandoz Ltd) | On Formulary | ||||
| chloramphenicol | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Paediatric Emergency ENT Guidelines
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
CHLORAMPHENICOL
Injection formulation is Hospital Only |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
| Powder for solution for injection | |||||
| Chloramphenicol (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CHLORAMPHENICOL
Injection formulation is Hospital Only |
|||||
| Ear drops | |||||
| Chloramphenicol (Non-proprietary) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Paediatric Emergency ENT Guidelines
|
|||||
| Eye drops | |||||
| Chloramphenicol (Non-proprietary) | On Formulary | ||||
| ciprofloxacin | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
CIPROFLOXACIN
First line for fistulating Crohn's disease (un-licensed) |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Ciprofloxacin ear drops -
Use eye drops |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| Oral suspension | |||||
| Ciproxin (Bayer Plc) | On Formulary | ||||
| Infusion | |||||
| Ciprofloxacin (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| Solution for infusion | |||||
| Ciprofloxacin (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| clarithromycin | On Formulary | ||||
|
CLARITHROMYCIN
Injection formulation is Hospital Only |
|||||
|
Contacting Micro 2015
|
|||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
| Oral suspension | |||||
| Clarithromycin (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| clindamycin | On Formulary | ||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
CLINDAMYCIN
Injection formulation is Hospital Only |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| Solution for injection | |||||
| Clindamycin (Non-proprietary) | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
CLINDAMYCIN
Injection formulation is Hospital Only |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| Dalacin C (Pfizer Ltd) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CLINDAMYCIN
Injection formulation is Hospital Only |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| co-amoxiclav | On Formulary | ||||
|
Penicillin allergy poster
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
|
Peri-orbital cellulitis in children protocol 2012
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
CO-AMOXICLAV
Injection is hospital only |
|||||
| co-fluampicil | Off Formulary | ||||
| co-trimoxazole | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
CO-TRIMOXAZOLE
Injection formulation is Hospital Only |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
| Oral suspension | |||||
| Co-trimoxazole (Non-proprietary) | On Formulary | ||||
| colistimethate sodium | On Formulary |
NICE TA276 |
|||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
| Powder for solution for injection | |||||
| Colomycin (Teva UK Ltd) | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
| Powder for nebuliser solution | |||||
| Promixin (Zambon UK Ltd) | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
| daptomycin | Hospital Only | ||||
|
Daptomycin
On Micro/ID advice only |
|||||
| Powder for solution for infusion | |||||
| Daptomycin (Non-proprietary) | Hospital Only | ||||
| Cubicin (Merck Sharp & Dohme (UK) Ltd) | Hospital Only | ||||
| demeclocycline hydrochloride | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
| doxycycline | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| ertapenem | Off Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
ERTAPENEM
Use on micro/ID advice only |
|||||
| Powder for solution for infusion | |||||
| Ertapenem (Non-proprietary) | Off Formulary | ||||
| Invanz (Merck Sharp & Dohme (UK) Ltd) | Off Formulary | ||||
| erythromycin | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
ERYTHROMYCIN
Injection formulation is hospital only |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2017
CF DRUG DOSES 2017 |
|||||
|
ERYTHROMYCIN
Second line for gastro-intestinal stasis |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH |
|||||
|
Non-CF Prescribing Pathway
Non-CF prescribing pathway 2018 |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Gastro-resistant tablet | |||||
| Erythromycin (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
| Oral suspension | |||||
| Erythromycin (Non-proprietary) | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
| Powder for solution for infusion | |||||
| Erythromycin (Non-proprietary) | Hospital Only | ||||
| flucloxacillin | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Peri-orbital cellulitis in children protocol 2012
|
|||||
|
Contacting Micro 2015
|
|||||
|
FLUCLOXACILLIN
Flucloxacillin injection is hospital only |
|||||
|
CF drug doses 2017
CF drug doses 2017 |
|||||
|
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH |
|||||
|
Non-CF Bronchiestisis Drug doses 2018
Non-CF Bronchiestisis Drug doses |
|||||
| Oral solution | |||||
| Flucloxacillin (Non-proprietary) | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Barts Health Antibiotic Dosing for Children in Theatres MARCH 2015
see attached |
|||||
|
Peri-orbital cellulitis in children protocol 2012
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
| Powder for solution for injection | |||||
| Flucloxacillin (Non-proprietary) | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Barts Health Antibiotic Dosing for Children in Theatres MARCH 2015
see attached |
|||||
|
Peri-orbital cellulitis in children protocol 2012
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Flucloxacillin
Flucloxacillin injection is hospital only |
|||||
| fosfomycin | On Formulary | ||||
| fusidic acid | On Formulary | ||||
|
Contacting Micro 2015
Contacting Micro 2015 |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
CF Drug Doses Aug 17 |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 Dec 2016 Barts Health |
|||||
| Oral suspension | |||||
| Fucidin (LEO Pharma) | On Formulary | ||||
|
Contacting Micro 2015
Contacting Micro 2015 |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 Dec 2016 Barts Health |
|||||
|
Cystic Fibrosis Drug Doses
CF Drug Doses changes Aug 17 |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
CF & non CF Prescribing Pathway |
|||||
| Powder and solvent for solution for infusion | |||||
| Fusidic acid (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
Contacting Micro 2015 |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
CF Prescribing Pathway Final Version Dec 2015 |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 Dec 2016 Barts Health |
|||||
|
Cystic Fibrosis Drug Doses
CF Drug Doses changes Aug 17 |
|||||
| gentamicin | On Formulary | ||||
|
Antibiotic guidelines for Children May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Antibiotic line lock Guideline - paeds
see attached |
|||||
|
GENTAMICIN
Hospital use only |
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
13.12.19 Paediatric gentamicin guidance during amikacin shortage
please see attached memo |
|||||
| Solution for injection | |||||
| Gentamicin (Non-proprietary) | On Formulary | ||||
|
Antibiotic guidelines for Children May 2015
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Antibiotic line lock Guideline - paeds
see attached |
|||||
|
CF DRUG DOSES 2017
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Gentamicin
Hospital Only |
|||||
| Cidomycin (Advanz Pharma) | On Formulary | ||||
|
Antibiotic guidelines for Children May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
CF DRUG DOSES 2017
|
|||||
| imipenem with cilastatin | On Formulary | ||||
|
CF DRUG DOSES 2017
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Antibiotic guidelines for Children May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
IMIPENEM WITH CILASTATIN
Hospital use only |
|||||
|
NEONATAL FORMULARY VERSION 10 BARTS HEALTH
See attached |
|||||
| levofloxacin | Off Formulary | ||||
| linezolid | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
LINEZOLID
Injection formulation is Hospital use Only |
|||||
| Oral suspension | |||||
| Zyvox (Pfizer Ltd) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 Barts Health |
|||||
|
Linezolid
Hospital use only |
|||||
| Infusion | |||||
| Linezolid (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Note:
Injection formulation is Hospital Only |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 2016 Barts Health |
|||||
| Zyvox (Pfizer Ltd) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Note:
Injection formulation is Hospital Only |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 2016 Barts Health |
|||||
| lymecycline | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
| meropenem | On Formulary | ||||
|
CF DRUG DOSES 2017
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
MEROPENEM
Hospital use only |
|||||
| Powder for solution for injection | |||||
| Meropenem (Non-proprietary) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Antibiotic guidelines for Children May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
CF DRUG DOSES 2017
|
|||||
| metronidazole | On Formulary | ||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Peri-orbital cellulitis in children protocol 2012
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
METRONIDAZOLE
First line for fistulating Crohn's disease (un-licensed) |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
see attached |
|||||
|
Metronidazole
Please note that the injection is HOSPITAL PHARMACY. |
|||||
| minocycline | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
| moxifloxacin | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
CF Drug Doses 2015 |
|||||
|
Contacting Micro 2015
Contacting Micro 2015 |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
CF Prescribing Pathway Version 5 Dec 2015 |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
CF and non CF Prescribing Pathway |
|||||
| Infusion | |||||
| Moxifloxacin (Non-proprietary) | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
CF Drug Doses 2015 |
|||||
|
Contacting Micro 2015
Contacting Micro 2015 |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
CF Prescribing Pathway Dec 2015 |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
CF & Non CF Prescribing Pathway |
|||||
| ofloxacin | Off Formulary | ||||
| Eye drops | |||||
| Exocin (AbbVie Ltd) | On Formulary | ||||
| oxytetracycline | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
| phenoxymethylpenicillin | On Formulary | ||||
|
Sickle-Cell-Disease Management in Children
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Penicillin allergy poster
|
|||||
| Oral solution | |||||
| Phenoxymethylpenicillin (Non-proprietary) | On Formulary | ||||
|
Penicillin allergy poster
Penicillin allergy poster |
|||||
|
Sickle-Cell-Disease Management in Children
see attached |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
| piperacillin with tazobactam | On Formulary | ||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Penicillin allergy poster
|
|||||
|
Rapid desensitisation protocol October 2013 Barts Health
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Rapid Desensitisation Protocol
|
|||||
|
PIPERACILLIN WITH TAZOBACTAM
Hospital use only |
|||||
| pivmecillinam hydrochloride | Hospital Only | ||||
| rifabutin | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
RIFABUTIN
Hospital Use Only |
|||||
| streptomycin | Off Formulary | ||||
| sulfadiazine | On Formulary | ||||
|
Silver Sulfadiazine (Sulphadiazine)
Can be used for treatment of granulomas |
|||||
| teicoplanin | On Formulary | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY BARTS HEALTH
see attached |
|||||
|
TEICOPLANIN
Hospital use only |
|||||
| Powder and solvent for solution for injection | |||||
| Targocid (Sanofi) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
Targocid®
Hospital use Only |
|||||
| tetracycline | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
ACMP guidelines on malaria prevention in UK travellers
ACMP guidelines on malaria prevention in UK travellers |
|||||
| tobramycin | On Formulary |
NICE TA276 |
|||
|
Double-checking prompt for the preparation and administration of intravenous aminoglycosides/vancomycin in neonates and paediatrics
|
|||||
|
TOBRAMYCIN
Injection is hospital only |
|||||
|
Cystic fibrosis - nebulised
1st line: Bramitob brand - via homecare only for discharge |
|||||
|
Tobramycin dosing & monitoring guidance 2024
tobramycin guidance for CF & non - CF respiratory patients |
|||||
| Solution for injection | |||||
| Tobramycin (Non-proprietary) | On Formulary | ||||
|
Antibiotic guidelines for Children May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
CF DRUG DOSES 2017
|
|||||
|
Tobramycin
Hospital Use Only |
|||||
| Inhalation powder | |||||
| Tobi Podhaler (Viatris UK Healthcare Ltd) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
CF DRUG DOSES 2017
see attached |
|||||
| trimethoprim | On Formulary | ||||
|
Cystic Fibrosis Drug doses 2017
see attached |
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
NEONATAL FORMULARY BARTS HEALTH
See attached |
|||||
| Oral suspension | |||||
| Trimethoprim (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
| vancomycin | On Formulary | ||||
|
Vancomycin line locks
Formulary approved. |
|||||
|
Double-checking prompt for the preparation and administration of intravenous aminoglycosides/vancomycin in neonates and paediatrics
|
|||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Intravenous Antibiotic Dosing In Paediatric Patients In Theatre
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
|
|||||
|
Contacting Micro 2015
|
|||||
|
Antibiotic line lock Guideline - paeds
|
|||||
|
Cystic Fibrosis Drug Doses
See attached |
|||||
|
NEONATAL FORMULARY 2016 BARTS HEALTH
See attached |
|||||
|
VANCOMYCIN
Injection formulation is hospital only |
|||||
| Anti-infective / Leprosy | |||||
| dapsone | Hospital Only | ||||
| rifampicin | Hospital Only | ||||
| Anti-infective / Tuberculosis | |||||
| cycloserine | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
CYCLOSERINE
Hospital Use Only |
|||||
|
Shortage memo - cycloserine
Cycloserine 250mg capsules are out of stock with no confirmed resupply date. There are no other licensed strengths of cycloserine available in the UK market. Cycloserine is indicated for treatment of multi-drug resistant tuberculosis (MDR TB). Terizidone 250mg capsules, a derivative of cycloserine, will be used as an alternative. Terizidone is currently not licensed in the UK. Please see the memo attached for further information on this medicine shortage. |
|||||
| ethambutol hydrochloride | Hospital Only | ||||
|
Contacting Micro 2015
|
|||||
|
Cystic Fibrosis Drug Doses
|
|||||
|
ETHAMBUTOL HYDROCHLORIDE
Hospital Use Only |
|||||
|
Non-CF Prescribing Pathway 2018
Non-CF Prescribing Pathway 2018 |
|||||
| isoniazid | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
ISONIAZID
Hospital use only |
|||||
|
Isoniazid Liquid
50mg/5mL - Unlicensed formulation - ON FORMULARY |
|||||
| Solution for injection | |||||
| Isoniazid (Non-proprietary) | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Isoniazid
Hospital use only |
|||||
| pyrazinamide | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
Difficult to Obtain Letter
|
|||||
|
PYRAZINAMIDE
Hospital Use Only |
|||||
| rifabutin | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
RIFABUTIN
Hospital Use Only |
|||||
| rifampicin | Hospital Only | ||||
|
Cystic Fibrosis Drug Doses
see attached |
|||||
|
RIFAMPICIN
|
|||||
|
Barts Health Paediatric Antibiotic Guidelines May 2015
see attached |
|||||
|
Contacting Micro 2015
see attached |
|||||
| rifampicin with isoniazid | On Formulary | ||||
|
Contacting Micro 2015
|
|||||
|
RIFAMPICIN WITH ISONIAZID
Hospital Use Only |
|||||
| rifampicin with isoniazid and pyrazinamide | On Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
Difficult to Obtain Letter
see attached |
|||||
|
Rifater®
Hospital Use Only |
|||||
| streptomycin | On Formulary | ||||
|
STREPTOMYCIN
Hospital use only |
|||||
|
Contacting Micro 2015
see attached |
|||||
| Anti-infective / Urinary tract infections | |||||
| nitrofurantoin | On Formulary | ||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Nitrofurantoin liquid - Non formulary
Switch from nitrofurantoin liquid to nitrofurantoin tablets
As part of the Trust cost improvement programme, Pharmacy will no longer procure nitrofurantoin liquid and is now non-formulary, effective from 1st May 2019. Nitrofurantoin tablets are still available. Patients requiring administration as a liquid can disperse the tablets in 10mL water for 5 minutes giving a bright yellow fine dispersion that flushes easily without blockage1. Please contact your clinical pharmacy teams if you have any queries relating to this. Tel: 0203 246 0120 Reference
|
|||||
| Oral suspension | |||||
| Nitrofurantoin (Non-proprietary) | Off Formulary | ||||
|
Contacting Micro 2015
see attached |
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
see attached |
|||||